Cargando…
Identification of Monotonically Differentially Expressed Genes for IFN-β-Treated Multiple Sclerosis Patients
Multiple sclerosis (MS) is a common neurological disability of the central nervous system. Immune-modulatory therapy with interferon-β (IFN-β) has been used as a first-line treatment to prevent relapses in MS patients. While the therapeutic mechanism of IFN-β has not been fully elucidated, the data...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930778/ https://www.ncbi.nlm.nih.gov/pubmed/31915697 http://dx.doi.org/10.1155/2019/5647902 |